Divi's Laboratories · NSE: DIVISLAB · BSE: 532488
Q4 FY19 results · Jan–Mar 2019
Divi's Laboratories reported revenue from operations of ₹0.00 crore and net profit of ₹0.00 crore for Q4 FY19 (Jan–Mar 2019), on a consolidated basis.
| Item | Q4 FY19 | Q4 FY18 | YoY | Q3 FY19 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 0.00 | — | — | — | — |
| Other income | 0.00 | — | — | — | — |
| Total income | 0.00 | — | — | — | — |
| Profit before tax | 0.00 | — | — | — | — |
| Net profit for the period | 0.00 | — | — | — | — |
| EPS, basic (₹) | 0.00 | — | — | — | — |
| Net margin (%) | — | — | — |
| Item | Q4 FY19 | Q4 FY18 | YoY | Q3 FY19 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 1,256.43 | — | — | 1,342.92 | −6.4% |
| Other income | 41.73 | — | — | 34.56 | +20.7% |
| Total income | 1,298.16 | — | — | 1,377.48 | −5.8% |
| Profit before tax | 410.38 | — | — | 512.89 | −20.0% |
| Net profit for the period | 289.35 | — | — | 379.49 | −23.8% |
| EPS, basic (₹) | 10.90 | — | — | 14.29 | −23.7% |
| Net margin (%) | 23.0 | — | 28.3 |
Consolidated
- Filed with BSE
- 25 May 2019, 17:17 IST
- Board meeting
- 25 May 2019
- Period
- 01 Jan 2019 to 31 Mar 2019
- Review status
- Audited
- Source
- XBRL filing on BSE
Standalone
- Filed with BSE
- 25 May 2019, 17:15 IST
- Board meeting
- 25 May 2019
- Period
- 01 Jan 2019 to 31 Mar 2019
- Review status
- Audited
- Source
- XBRL filing on BSE